Welcome to our dedicated page for Keen Vision Acquisition SEC filings (Ticker: kvacw), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Keen Vision Acquisition's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Keen Vision Acquisition's regulatory disclosures and financial reporting.
Keen Vision Acquisition Corporation ("KVAC") has filed a PRE 14A preliminary proxy statement to convene an Extraordinary General Meeting on 23 July 2025 in Hong Kong. Shareholders will vote on three key proposals that directly affect the special-purpose acquisition company’s (SPAC) life span and capital structure.
Proposal 1 – Trust Amendment: KVAC seeks authority to extend the deadline for commencing liquidation of its $72.6 million trust account up to six additional one-month periods, shifting the current cut-off from 27 July 2025 to 27 January 2026. Each monthly extension would require a deposit of $0.03 per remaining public share ("Extension Payment") instead of the existing flat $200,000 monthly fee. The change reduces the sponsor’s cash outlay when public share redemptions shrink the float and provides incremental optionality rather than a single long extension.
Proposal 2 – Charter Amendment: To give full legal effect to Proposal 1, shareholders must adopt a Third Amended & Restated Memorandum and Articles that formally sets the new outside date at 27 January 2026.
Proposal 3 – Adjournment: Allows the chair to adjourn the meeting if there are insufficient votes to pass Proposals 1 or 2, facilitating additional proxy solicitation.
Public shareholders may elect to redeem their ordinary shares for a pro-rata share of the trust regardless of how they vote. Redemption requests must reach Continental Stock Transfer & Trust at least two business days before the meeting via share certificate delivery or DWAC. If Proposals 1 & 2 fail and no business combination closes by the current deadline, the company will liquidate and redeem 100 % of Public Shares within ten business days.
The record date is 26 June 2025. The Trust Amendment requires approval by at least 50 % of all outstanding ordinary shares; the Charter Amendment and Adjournment proposals need a majority of shares present and voting. The Board unanimously recommends voting "FOR" all proposals, asserting that the lower, per-share extension cost aligns shareholder and sponsor interests while preserving the option to consummate a value-enhancing business combination.